Insider Transactions in Q2 2021 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+2.2%
|
$15,624
$3.2 P/Share
|
|
Jun 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,762
+2.06%
|
$14,286
$3.5 P/Share
|
|
Jun 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.91 P/Share
|
|
Jun 01
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,198
+1.86%
|
$12,594
$3.97 P/Share
|
|
May 14
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,940
+1.78%
|
$15,760
$4.23 P/Share
|
|
May 03
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.84 P/Share
|
|
Apr 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,771
+1.74%
|
$15,084
$4.42 P/Share
|
|
Apr 26
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,500
-0.12%
|
$30,000
$4.47 P/Share
|
|
Apr 23
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$15,000
$3.95 P/Share
|
|
Apr 22
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$15,000
$3.52 P/Share
|
|
Apr 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,474
+3.45%
|
$14,948
$2.23 P/Share
|
|
Apr 05
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+14.29%
|
$10,000
$2.04 P/Share
|
|
Apr 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.16 P/Share
|